GKIM
CMD

GW&K Investment Management’s Cantel Medical Corporation CMD Stock Holding History

GW&K Investment Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1
Closed – – 415
2020
Q3 		$0 Hold
1
– – ﹤0.01% 405
2020
Q2 		$0 Sell
1
-227,181
-100% -$8.48M ﹤0.01% 394
2020
Q1 		$8.16M Sell
227,182
-119,480
-34% -$6.79M 0.14% 197
2019
Q4 		$24.6M Sell
346,662
-99,665
-22% -$7.23M 0.33% 137
2019
Q3 		$33.4M Buy
446,327
+33,841
+8% +$2.87M 0.47% 81
2019
Q2 		$33.3M Sell
412,486
-8,457
-2% -$595K 0.5% 68
2019
Q1 		$28.2M Buy
420,943
+65,352
+18% +$4.95M 0.45% 86
2018
Q4 		$26.5M Buy
355,591
+36,902
+12% +$3.05M 0.52% 69
2018
Q3 		$29.3M Sell
318,689
-1,551
-0.5% -$148K 0.47% 91
2018
Q2 		$31.5M Sell
320,240
-3,032
-0.9% -$339K 0.52% 68
2018
Q1 		$36M Sell
323,272
-1,307
-0.4% -$146K 0.61% 51
2017
Q4 		$33.4M Sell
324,579
-60,796
-16% -$6.06M 0.57% 62
2017
Q3 		$36.3M Sell
385,375
-1,234
-0.3% -$97.4K 0.61% 60
2017
Q2 		$30.1M Sell
386,609
-12,163
-3% -$914K 0.52% 86
2017
Q1 		$31.9M Sell
398,772
-6,027
-1% -$479K 0.6% 68
2016
Q4 		$31.9M Sell
404,799
-59,124
-13% -$4.59M 0.62% 59
2016
Q3 		$36.2M Sell
463,923
-7,722
-2% -$560K 0.68% 51
2016
Q2 		$32.4M Sell
471,645
-16,595
-3% -$1.14M 0.67% 54
2016
Q1 		$34.8M Sell
488,240
-10,863
-2% -$682K 0.77% 42
2015
Q4 		$31M Sell
499,103
-17,537
-3% -$1.07M 0.73% 47
2015
Q3 		$29.3M Buy
516,640
+9,553
+2% +$506K 0.7% 56
2015
Q2 		$27.2M Sell
507,087
-15,247
-3% -$742K 0.62% 65
2015
Q1 		$24.8M Sell
522,334
-5,725
-1% -$253K 0.56% 72
2014
Q4 		$22.8M Sell
528,059
-2,878
-0.5% -$118K 0.55% 73
2014
Q3 		$18.3M Buy
530,937
+5,724
+1% +$202K 0.48% 83
2014
Q2 		$19.2M Buy
525,213
+27,060
+5% +$918K 0.49% 82
2014
Q1 		$16.8M Buy
498,153
+1,010
+0.2% +$33.3K 0.45% 89
2013
Q4 		$16.9M Buy
497,143
+261,555
+111% +$9.06M 0.46% 89
2013
Q3 		$7.5M Buy
+235,588
New +$6.27M 0.23% 125

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

GW&K Investment Management's CMD Position: Q4 2020 in Review

GW&K Investment Management sold out of Cantel Medical Corporation (CMD) in Q4 2020, closing a stake of 1 share.

GW&K Investment Management first reported a position in CMD in Q3 2013 and held it in 29 quarters. The position peaked at $36.3M in Q3 2017. 229 funds tracked by Wall St. Rank hold CMD as of Q4 2020.

  • GW&K Investment Management reported no remaining Cantel Medical Corporation position as of Q4 2020 after selling out during the quarter.
  • GW&K Investment Management sold 1 Cantel Medical Corporation share in Q4 2020.
  • GW&K Investment Management first reported a position in Cantel Medical Corporation in Q3 2013 and held it in 29 quarters.
  • GW&K Investment Management's Cantel Medical Corporation position peaked at $36.3M in Q3 2017.
  • 229 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2020.

Based on GW&K Investment Management's 13F filing for Q4 2020, filed 5 Feb 2021.